FOXP3 was expressed at similar levels between BD patients [1.62 ± 0.60%], RA patients [1.58 ± 0.44%] and healthy controls [1.67 ± 0.59%; P = 0.85 and P = 0.77]. Here, FOXP3 is linked to rheumatoid arthritis.